Vanguard Group Inc Ocular Therapeutix, Inc Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Vanguard Group Inc holds 8,392,175 shares of OCUL stock, worth $102 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,392,175

Previous 8,364,515 0.33%

Holding current value

$102 Million

Previous $61.3 Million 27.02%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$6.02 - $9.46 $166,513 - $261,663	27,660 Added 0.33%	8,392,175 $77.9 Million
Q1 2025 May 09, 2025	SELL	$5.93 - $9.08 $708,030 - $1.08 Million	-119,398 Reduced 1.41%	8,364,515 $61.3 Million
Q4 2024 Feb 11, 2025	BUY	$8.33 - $11.47 $830,750 - $1.14 Million	99,730 Added 1.19%	8,483,913 $72.5 Million
Q3 2024 Nov 13, 2024	SELL	$6.45 - $9.23 $1.47 Million - $2.1 Million	-227,918 Reduced 2.65%	8,384,183 $72.9 Million
Q2 2024 Aug 13, 2024	BUY	$4.2 - $8.69 $5.78 Million - $12 Million	1,376,970 Added 19.03%	8,612,101 $58.9 Million
Q1 2024 May 10, 2024	BUY	$3.85 - $10.93 $8.15 Million - $23.1 Million	2,117,029 Added 41.36%	7,235,131 $65.8 Million
Q4 2023 Feb 14, 2024	BUY	$2.08 - $4.52 $2.2 Million - $4.78 Million	1,057,123 Added 26.03%	5,118,102 $22.8 Million
Q3 2023 Nov 14, 2023	BUY	$3.14 - $5.04 $25,597 - $41,086	8,152 Added 0.2%	4,060,979 $12.8 Million
Q2 2023 Aug 14, 2023	BUY	$4.6 - $7.64 $52,610 - $87,378	11,437 Added 0.28%	4,052,827 $20.9 Million
Q1 2023 May 15, 2023	BUY	$2.79 - $6.27 $180,058 - $404,646	64,537 Added 1.62%	4,041,390 $21.3 Million
Q4 2022 Feb 10, 2023	BUY	$2.61 - $4.41 $65,372 - $110,457	25,047 Added 0.63%	3,976,853 $11.2 Million
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $217,812 - $346,157	53,255 Added 1.37%	3,951,806 $16.4 Million
Q2 2022 Aug 12, 2022	SELL	$3.01 - $5.22 $893,533 - $1.55 Million	-296,855 Reduced 7.08%	3,898,551 $15.7 Million
Q1 2022 May 13, 2022	BUY	$4.83 - $7.35 $562,129 - $855,415	116,383 Added 2.85%	4,195,406 $20.8 Million
Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $2.43 Million - $4.76 Million	394,174 Added 10.7%	4,079,023 $28.4 Million
Q3 2021 Nov 12, 2021	BUY	$9.7 - $14.34 $154,074 - $227,776	15,884 Added 0.43%	3,684,849 $36.8 Million
Q2 2021 Aug 13, 2021	BUY	$13.43 - $19.16 $49.3 Million - $70.3 Million	3,668,965 New	3,668,965 $52 Million

Others Institutions Holding OCUL

# of Institutions

204

Shares Held

137M

Call Options Held

743K

Put Options Held

321K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $933M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Ocular Therapeutix, Inc Transaction History